Skip to content

GH Cardiologist

Active
Private limited companyfounded 20214 years activeMarche, Bois Notre Dame 18, 6900 Marche-en-Famenne, BelgiumKBO/BCE: BE 0775.754.035
Summary

GH Cardiologist has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1,500 and a net result of €158,844. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 5% of 20,374 sector peers (NACE 86, fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).

Overview

Activity
Specialist medical practice
NACE 86220
1 site
Size
€157,309total assets 2025
Equity
€1,500
Profit
€158,844
Turnover not published (abridged schema)
Financial health
90 Excellent Checked score 2025
Bankruptcy probability, 12 months
< 0.1%
Structure
Accounts filed 28 days late0 of 2 deeds read
Why 90- Equity €1,500 (1.0% of total assets)+ Sector Human health activities (NACE 86)+ Size: total assets €157,309+ Liquidity: current ratio 0.79, cash €30,429Show the evidence

Checked score

Score 2025
90 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 23% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Average
Solvency 26-71
equity 1.0% of total assets
Liquidity 28-24
short-term debt 83.6% · cash 19.3%
Profitability 100+4
return on assets 101.0%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (23,969 companies)
Last 24 months 11-2024: 0.2% 12-2024: 0.2%● unchanged vs 11-2024 01-2025: 0.2%● unchanged vs 12-2024 02-2025: 0.2%● unchanged vs 01-2025 03-2025: 0.3%▲ +0.1 percentage points vs 02-2025highest value 04-2025: 0.1%▼ -0.2 percentage points vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025 09-2025: < 0.1%▼ -0.1 percentage points vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025lowest value 11-2025: < 0.1%● unchanged vs 10-2025lowest value 12-2025: < 0.1%● unchanged vs 11-2025lowest value 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: 0.1%▲ +0.1 percentage points vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.2%▲ +0.1 percentage points vs 07-2026 09-2026: < 0.1%▼ -0.2 percentage points vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 5% on solvency, 5% on liquidity, 80% on profitability and 2% on growth.

The bankruptcy probability was computed on 06-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Six signals.
−lowers risk+raises risk○neutral
lowers risk · Sector Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €157,309
The company's size counts in the probability; how much depends on the rest of its profile.
NBB · annual accounts
lowers risk · Liquidity: current ratio 0.79, cash €30,429
NBB · annual accounts
raises risk · Equity €1,500 (1.0% of total assets)
NBB · annual accounts
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 5% of 20374 sector peers (2025).
NBB · sector comparison
Position among 20374 sector peers
Solvency
better than 5%
← weakest strongest →
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-08-2026, 28 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 4 filings
Deviation from the deadline
2025
28 days late
2024
14 days late
2023
20 days late
2022
21 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 4 accounts on average 21 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 21 August (4 of the last 4 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
07-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Checked from 2021 on.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · micro…
  2. Highest result since 2022net €158,844 ▲130%
  3. Annual accounts filedfiscal year 2024 · micro…

Key points

  • Caution: Equity fell in 2025from €226,309 to €1,500 ▼ 99.3% View
  • Caution: Among the weakest 5% on equitysector median €124,492 · 20,377 companies €1,500 View
  • Total assets 20254 fiscal years filed €157,309 View

By topic

Financials

Fiscal year
2025
Total assets
€157,309
Profit
€158,844
Solvency
1.0%
Total assets▼ 49.7%
Net result
20222025
Go to Financials

Timeline

Events
7
Since
2023
Next accounts
by 31-07-2027
  1. 31-12-2024Equity above €200,000
  2. 20-08-2024Annual accounts filed
  3. 31-12-2023Equity above €150,000
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
14-10-2021
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.